Annual Drug Patent Expirations for KISQALI+FEMARA+CO-PACK+%28COPACKAGED%29
Kisqali Femara Co-pack (copackaged) is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and sixty-five patent family members in fifty-one countries.
The generic ingredient in KISQALI FEMARA CO-PACK (COPACKAGED) is letrozole; ribociclib succinate. One supplier is listed for this compound. Additional details are available on the letrozole; ribociclib succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
